Prostate Cancer
February 6, 2023
Video file
Please connect to access this resource and get a more personalized Campus experience
No account yet? Request access
Executive summary
Jason Efstathiou gives an overview of protons for prostate cancer. He covers the clinical potential, the available and comparative data, and the future opportunities in the field. Watch the talk's recording now!
Top cancer treatments
Guest speakers
Jason
Efstathiou
Radiation Oncologist
Massachusetts General Hospital - MGH
Related contents
Proton Therapy Publication
September 2024
Secondary Cancer in Prostate Cancer Patients Treated With Advanced External Beam Radiation Therapy.
Proton Therapy Publication
September 2024
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
Proton Therapy Publication
October 2024
Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer.
Proton Therapy Publication
June 2024
Effectiveness and Safety of Carbon Ion Radiotherapy in Solid Tumors: A Systematic Review and Meta-Analysis.
Proton Therapy Publication
May 2024
Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.
Proton Therapy Publication
May 2024
PTCOG Gastrointestinal Subcommittee Lower Gastrointestinal Tract Malignancies Consensus Statement.
Proton Therapy Publication
February 2024
A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer.
Proton Therapy Publication
March 2024
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis. This review.
Proton Therapy Publication
November 2020
Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer.